<p>Inflammation is a biological phenomenon beneficial for homeostasis, but it is unfavorable if dysregulated. Although major progress has been made in characterizing inflammation in specific diseases, a global, holistic understanding is still elusive. This is particularly intriguing, considering its function for human health and the potential for modern medicine if fully deciphered. In this study, we leveraged advances in single-cell transcriptomics to delineate inflammatory processes of circulating immune cells during infection, immune-mediated inflammatory diseases and cancer. Our single-cell atlas of more than 6.5 million peripheral blood mononuclear cells from 1,047 patients (56% female, 43% male) and 19 diseases allowed us to learn a comprehensive model of inflammation in circulating immune cells. The atlas expands current knowledge of the biology of inflammation of immune-mediated diseases, acute and chronic inflammatory diseases, infections and solid tumors and lays the foundation to develop a disease classification framework using unsupervised as well as explainable machine learning. Beyond a disease-centered analysis, we charted altered activity of inflammatory molecules in peripheral blood cells, depicting discriminative inflammation-related genes to further understand mechanisms of inflammation. We present a rich resource for the community and lay the groundwork for learning a classifier for inflammatory diseases, presenting cells in circulation as living biomarkers.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Interpretable inflammation landscape of circulating immune cells

  • Laura Jiménez-Gracia,
  • Davide Maspero,
  • Sergio Aguilar-Fernández,
  • Francesco Craighero,
  • Maria Boulougouri,
  • Max Ruiz,
  • Domenica Marchese,
  • Ginevra Caratù,
  • Jose Liñares-Blanco,
  • Miren Berasategi,
  • Ricardo O. Ramirez Flores,
  • Angela Sanzo-Machuca,
  • Ana M. Corraliza,
  • Hoang A. Tran,
  • Rachelly Normand,
  • Jacquelyn Nestor,
  • Yourae Hong,
  • Tessa Kole,
  • Petra van der Velde,
  • Frederique Alleblas,
  • Flaminia Pedretti,
  • Adrià Aterido,
  • Martin Banchero,
  • German Soriano,
  • Eva Román,
  • Maarten van den Berge,
  • Azucena Salas,
  • Jose Manuel Carrascosa,
  • Antonio Fernández Nebro,
  • Eugeni Domènech,
  • Juan D. Cañete,
  • Jesús Tornero,
  • Javier P. Gisbert,
  • Ernest Choy,
  • Giampiero Girolomoni,
  • Britta Siegmund,
  • Antonio Julià,
  • Violeta Serra,
  • Roberto Elosua,
  • Sabine Tejpar,
  • Silvia Vidal,
  • Martijn C. Nawijn,
  • Ivo Gut,
  • Julio Saez-Rodriguez,
  • Sara Marsal,
  • Alexandra-Chloé Villani,
  • Juan C. Nieto,
  • Holger Heyn

摘要

Inflammation is a biological phenomenon beneficial for homeostasis, but it is unfavorable if dysregulated. Although major progress has been made in characterizing inflammation in specific diseases, a global, holistic understanding is still elusive. This is particularly intriguing, considering its function for human health and the potential for modern medicine if fully deciphered. In this study, we leveraged advances in single-cell transcriptomics to delineate inflammatory processes of circulating immune cells during infection, immune-mediated inflammatory diseases and cancer. Our single-cell atlas of more than 6.5 million peripheral blood mononuclear cells from 1,047 patients (56% female, 43% male) and 19 diseases allowed us to learn a comprehensive model of inflammation in circulating immune cells. The atlas expands current knowledge of the biology of inflammation of immune-mediated diseases, acute and chronic inflammatory diseases, infections and solid tumors and lays the foundation to develop a disease classification framework using unsupervised as well as explainable machine learning. Beyond a disease-centered analysis, we charted altered activity of inflammatory molecules in peripheral blood cells, depicting discriminative inflammation-related genes to further understand mechanisms of inflammation. We present a rich resource for the community and lay the groundwork for learning a classifier for inflammatory diseases, presenting cells in circulation as living biomarkers.